MSI Financial Services’s Anika Therapeutics ANIK Stock Holding History

MSI Financial Services’s Portfolio ANIK Stock Details ANIK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$6K	Buy	113 +50	+79%	+$2.31K	﹤0.01%	3041
2016 Q3	$3K	Buy	+63	New	+$3.11K	﹤0.01%	3307
2016 Q2	–	Sell	-1,373	Closed	-$61K	–	3909
2016 Q1	$61K	Buy	+1,373	New	+$55.7K	﹤0.01%	1613
2014 Q3	–	Sell	-250	Closed	-$12K	–	2627
2014 Q2	$12K	Hold	250	–	–	﹤0.01%	1697
2014 Q1	$10K	Buy	+250	New	+$9.29K	﹤0.01%	1724

Other funds holding ANIK

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

AAM

AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MSI Financial Services's ANIK Position: Q4 2016 in Review

MSI Financial Services increased its Anika Therapeutics (ANIK) stake by 79% in Q4 2016, buying an estimated $2.31K and bringing the position to 113 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #3041.

MSI Financial Services first reported a position in ANIK in Q1 2014 and has held it in 5 quarters since. The position peaked at $61K in Q1 2016. 158 funds tracked by Wall St. Rank hold ANIK as of Q4 2016.

MSI Financial Services held 113 shares of Anika Therapeutics worth $6K as of Q4 2016.
MSI Financial Services bought 50 Anika Therapeutics shares in Q4 2016, an estimated $2.31K.
Anika Therapeutics made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #3041 holding.
MSI Financial Services first reported a position in Anika Therapeutics in Q1 2014 and has held it in 5 quarters since.
MSI Financial Services's Anika Therapeutics position peaked at $61K in Q1 2016.
158 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.